Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Dysfunction in Depression
Yashika Bansal, Anurag Kuhad
Current Neuropharmacology (2016) Vol. 14, Iss. 6, pp. 610-618
Open Access | Times Cited: 283

Showing 26-50 of 283 citing articles:

Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression
Maria S. Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110391-110391
Open Access | Times Cited: 70
Understanding Why Post-Stroke Depression May Be the Norm Rather Than the Exception: The Anatomical and Neuroinflammatory Correlates of Post-Stroke Depression
Tissa Wijeratne, Carmela Sales
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1674-1674
Open Access | Times Cited: 64
Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Gerwyn Morris, Adam J. Walker, Ken Walder, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2158-2182
Closed Access | Times Cited: 61
Animal models for the study of depressive disorder
Juhyun Song, Young‐Kook Kim
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 6, pp. 633-642
Open Access | Times Cited: 59
Ginsenoside Rg1 Reduced Microglial Activation and Mitochondrial Dysfunction to Alleviate Depression-Like Behaviour Via the GAS5/EZH2/SOCS3/NRF2 Axis
Junnan Li, Wei Gao, Zhonghui Zhao, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 2855-2873
Open Access | Times Cited: 53
Allostasis, Action, and Affect in Depression: Insights from the Theory of Constructed Emotion
Clare Shaffer, Christiana Westlin, Karen S. Quigley, et al.
Annual Review of Clinical Psychology (2022) Vol. 18, Iss. 1, pp. 553-580
Open Access | Times Cited: 50
A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury
Mengran Du, Chenrui Wu, Renqiang Yu, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4575-4589
Open Access | Times Cited: 48
Antioxidant Biomolecules and Their Potential for the Treatment of Difficult-to-Treat Depression and Conventional Treatment-Resistant Depression
María Eugenia Riveros, Alba Ávila, Koen Schruers, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 540-540
Open Access | Times Cited: 41
Diet and depression: A systematic review of whole dietary interventions as treatment in patients with depression
Jennifer Swainson, Matthew Reeson, Usama Malik, et al.
Journal of Affective Disorders (2023) Vol. 327, pp. 270-278
Closed Access | Times Cited: 34
Connecting Dots between Mitochondrial Dysfunction and Depression
Mehtab Khan, Yann Baussan, Étienne Hébert-Chatelain
Biomolecules (2023) Vol. 13, Iss. 4, pp. 695-695
Open Access | Times Cited: 28
How Oxidative Stress Induces Depression?
Na Ji, Mengzhu Lei, Yating Chen, et al.
ASN NEURO (2023) Vol. 15
Open Access | Times Cited: 27
Peripheral modulation of antidepressant targets MAO-B and GABAAR by harmol induces mitohormesis and delays aging in preclinical models
Luis Filipe Costa‐Machado, Esther García-Domínguez, Rebecca L. McIntyre, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Complete remission of depression and anxiety using a ketogenic diet: case series
Lori Calabrese, Rachel Frase, Mariam Ghaloo
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 14
Ferroptosis: a new antidepressant pharmacological mechanism
Guangheng Zhang, Shimeng Lv, Xia Zhong, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wenbo Wang, Da Pan, Qi Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 11
Intelligent Internet of Medical Things for Depression: Current Advancements, Challenges, and Trends
Md Belal Bin Heyat, Deepak Adhikari, Faijan Akhtar, et al.
International Journal of Intelligent Systems (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 1
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access | Times Cited: 1
Protective effects of resveratrol on mitochondrial function in the hippocampus improves inflammation-induced depressive-like behavior
Wenjin Chen, Jiankui Du, Xing Hu, et al.
Physiology & Behavior (2017) Vol. 182, pp. 54-61
Closed Access | Times Cited: 81
Low-Level Laser Irradiation Improves Depression-Like Behaviors in Mice
Zhiqiang Xu, Xiaobo Guo, Yang Yong, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 6, pp. 4551-4559
Open Access | Times Cited: 74
Hippocampal metabolic differences implicate distinctions between physical and psychological stress in four rat models of depression
Lanxiang Liu, Xinyu Zhou, Yuqing Zhang, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Is there neuroinflammation in depression? Understanding the link between the brain and the peripheral immune system in depression
Maria Antonietta Nettis, Carmine M. Pariante
International review of neurobiology (2020), pp. 23-40
Closed Access | Times Cited: 62
Creatine for the Treatment of Depression
Brent M. Kious, Douglas G. Kondo, Perry F. Renshaw
Biomolecules (2019) Vol. 9, Iss. 9, pp. 406-406
Open Access | Times Cited: 55
Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention
A.C. Rossetti, Maria Serena Paladini, Marco Andrea Riva, et al.
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107520-107520
Closed Access | Times Cited: 53
Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases
Feres José Mocayar Marón, Alejandra B. Camargo, Walter Manucha
Life Sciences (2020) Vol. 249, pp. 117513-117513
Closed Access | Times Cited: 51
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Jan Detka, Katarzyna Głombik
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 47

Scroll to top